全关节置换术后血糖变异性增高与不良结局相关
该单中心研究分析2001至2017年21487例全髋或全膝关节置换患者,最终纳入2360例全髋和2698例全膝患者,其中1007例(19.9%)有糖尿病。校正分析显示,血糖变异系数每增加10个百分点,住院时间增加6.1%(95%CI 5.1%至7.2%;p<0.001),假体周围关节感染风险增加20%(OR=1.20,95%CI 1.02至1.41;p=0.03),手术部位感染风险增加14%(OR=1.14,95%CI 1.00至1.31;p=0.06),90天死亡风险增加26%(OR=1.26,95%CI 0.98至1.61;p=0.07)。作者认为术后血糖变异性增高与手术部位感染和假体周围关节感染率增加相关,并可能有助于预测死亡风险。
要点
- 血糖变异系数每增加10个百分点,住院时间增加6.1%(95%CI 5.1%至7.2%;p<0.001)。
- 血糖变异系数每增加10个百分点,假体周围关节感染风险增加20%(OR=1.20,95%CI 1.02至1.41;p=0.03)。
- 血糖变异系数每增加10个百分点,手术部位感染风险增加14%(OR=1.14,95%CI 1.00至1.31;p=0.06),90天死亡风险增加26%(OR=1.26,95%CI 0.98至1.61;p=0.07)。
核心结论
- 术后血糖变异性增高与手术部位感染和假体周围关节感染率增加相关,并可能有助于预测全髋和全膝关节置换术后的死亡风险。
- 作者认为应努力控制术后早期血糖变异性,未来研究应探讨连续血糖监测在血糖波动大的患者亚组中的作用。
研究设计与样本
- 单中心分析2001至2017年接受全髋关节置换术(THA)或全膝关节置换术(TKA)的21487例患者数据。
- 纳入标准为每日至少2个术后血糖值或总体超过3个血糖值,血糖变异性采用变异系数评估。
- 最终队列包括2360例THA和2698例TKA患者,其中1007例(19.9%)有糖尿病。
- 不良结局包括住院时间延长、90天死亡率、再手术、假体周围关节感染和手术部位感染,假体周围关节感染采用肌肉骨骼感染学会标准定义。
- 证据等级为预后Level IV。
主要发现
- 较高的血糖变异性与住院时间延长、90天死亡率、假体周围关节感染和手术部位感染相关。
- 校正分析显示,血糖变异系数每增加10个百分点,住院时间增加6.1%(95%CI 5.1%至7.2%;p<0.001)。
- 血糖变异系数每增加10个百分点,死亡风险增加26%(OR=1.26,95%CI 0.98至1.61;p=0.07)。
- 血糖变异系数每增加10个百分点,假体周围关节感染风险增加20%(OR=1.20,95%CI 1.02至1.41;p=0.03),手术部位感染风险增加14%(OR=1.14,95%CI 1.00至1.31;p=0.06)。
- 这些关联独立于手术年份、年龄、体重指数、Elixhauser合并症指数、糖尿病诊断、住院期间胰岛素或类固醇使用以及住院期间平均血糖值。
关键数值与推荐
- 血糖变异性采用变异系数评估。
- 假体周围关节感染采用肌肉骨骼感染学会标准定义。
- 血糖变异系数每增加10个百分点,住院时间增加6.1%(95%CI 5.1%至7.2%;p<0.001)。
- 血糖变异系数每增加10个百分点,假体周围关节感染风险OR=1.20(95%CI 1.02至1.41;p=0.03),手术部位感染风险OR=1.14(95%CI 1.00至1.31;p=0.06),死亡风险OR=1.26(95%CI 0.98至1.61;p=0.07)。
临床怎么用
- 作者认为应努力控制术后早期血糖变异性。
- 作者建议未来研究应探讨连续血糖监测在血糖波动大的患者亚组中的作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Increased glucose variability during hospitalization has been associated with a longer length of stay in the hospital and a higher mortality rate following non-orthopaedic surgical procedures. Our aim was to investigate the association between glucose variability and postoperative complications following total joint arthroplasty. METHODS: We analyzed data on 21,487 patients who had undergone total hip arthroplasty (THA) or total knee arthroplasty (TKA) at a single center from 2001 to 2017. Patients with a minimum of 2 postoperative glucose values per day or >3 values overall were included in the study. Glucose variability was assessed using a coefficient of variation. Adverse outcomes included an increased length of stay in the hospital, 90-day mortality, reoperations, periprosthetic joint infection, and surgical site infection. Periprosthetic joint infection was defined using the Musculoskeletal Infection Society criteria. RESULTS: The final cohort included 2,360 patients who had undergone THA and 2,698 who had undergone TKA; 1,007 (19.9%) had diabetes. Higher glycemic variability was associated with an increased length of stay, 90-day mortality, periprosthetic joint infection, and surgical site infection. Adjusted analysis indicated that for every 10-percentage-point increase in the coefficient of variation, the length of stay increased by 6.1% (95% confidence interval [CI], 5.1% to 7.2%; p < 0.001), the risk of mortality increased by 26% (odds ratio [OR] = 1.26, 95% CI = 0.98 to 1.61; p = 0.07), and the risks of periprosthetic joint infection and surgical site infection increased by 20% (OR = 1.20, 95% CI = 1.02 to 1.41; p = 0.03) and 14% (OR = 1.14, 95% CI = 1.00 to 1.31; p = 0.06), respectively. These associations were independent of the year of surgery, age, body mass index, Elixhauser comorbidity index, diagnosis of diabetes, in-hospital use of insulin or steroids, and mean glucose values during hospitalization. CONCLUSIONS: Higher glucose variability in the postoperative period is associated with increased rates of surgical site and periprosthetic joint infections and may be a useful predictor of the risk of mortality following THA and TKA. Efforts should be made to control the glucose variability in the early postoperative period, and future studies should examine the role of continuous glucose monitoring in a subset of patients with high glucose fluctuations. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Shohat N, Restrepo C, Allierezaie A, et al. Increased Postoperative Glucose Variability Is Associated with Adverse Outcomes Following Total Joint Arthroplasty. J Bone Joint Surg Am. 2018. PMID: 29975266. doi:10.2106/JBJS.17.00798
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。